Evaluation of two replacement regimens in primary adrenal insufficiency patients. Effect on clinical symptoms, health-related quality of life and biochemical parameters-Reference-Cited by-同舟云学术

Evaluation of two replacement regimens in primary adrenal insufficiency patients. Effect on clinical symptoms, health-related quality of life and biochemical parameters

Published:2004-05 Issue:5 Volume:27 Page:449-454
ISSN:0391-4097
Container-title:Journal of Endocrinological Investigation
language:en
Short-container-title:J Endocrinol Invest

Author:

Alonso N.,Granada M. L.,Lucas A.,Salinas I.,Reverter J.,Oriol A.,Sanmartí A.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/BF03345290.pdf

Reference29 articles.

1. Ten S, New M, Maclaren N. Addison’s Disease 2001. Clinical Review 130. J Clin Endocrinol Metab 2001, 86: 2909–22.

2. Besser GM, Jeffcoate WJ. Endocrine and metabolic disease: adrenal diseases. Br Med J 1976, 1: 448–51.

3. Burke CW. Primary adrenocortical failure. In: A. Grossman ed. Clinical Endocrinology. 1t ed. Oxford: Blackwell Scientific Publications.1992, 393–404.

4. Thorn GW, Lauler DP. Clinical therapeutics of adrenal disorders. Am J Med 1972, 53: 673–84.

5. Kenny FM, Preeyasombat C, Migeon CJ. Cortisol production rate. II. Normal infants, children, and adults. Pediatrics, 1996, 37 (Suppl. 1): 34–42.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Vivo Formation of Adrenal Organoids in a Novel Porcine Model of Adrenocortical Cell Transplantation;Endocrinology;2024-07-01

2. The management of glucocorticoid deficiency: Current and future perspectives;Clinica Chimica Acta;2020-06

3. Répercussions métaboliques et cardiovasculaires de la substitution glucocorticoïde au cours de la maladie d’Addison;Pan African Medical Journal;2018

4. Group 6. Modalities and frequency of monitoring of patients with adrenal insufficiency. Patient education;Annales d'Endocrinologie;2017-12

5. Group 4: Replacement therapy for adrenal insufficiency;Annales d'Endocrinologie;2017-12